Pulmonary Insights | Responsive Medical Health WordPress Theme

- 18 DEC 15
Translational Pulmonary Science Center Uses Basic Science to Advance Diagnosis and Treatment of Rare Lung Diseases in Real Time
Understanding the pathogenesis, diagnosis, and treatment of lung disease requires the collaboration between basic and clinical scientists, and is the primary mission of the Translational Pulmonary Science Center (TPSC) at the University of Cincinnati Medical Center. Formed in 2013, the TPSC is a joint effort between the pulmonary divisions of Cincinnati Children’s Hospital Medical Center
Read more →
- Posted in
- News
- 14 DEC 15
Diffuse Cystic Lung Diseases: Definitive Diagnosis is Essential for Targeted Treatments
Diffuse cystic lung diseases (DCLDs) are uncommon and frequently misdiagnosed, in part because there are so many different causes. The most frequently encountered DCLDs in clinical practice are lymphangioleiomyomatosis (LAM), Birt-Hogg-Dubé syndrome (BHD), and pulmonary Langerhans cell histiocytosis (PLCH).1 But cystic lung disease can also be due to Light Chain Deposition Disease or a rare
Read more →
- Posted in
- News
- 14 DEC 15
Groundbreaking Research into Rare Lung Disease Pulmonary Alveolar Microlithiasis
The National Heart, Lung, and Blood Institute has awarded an R01 grant of nearly $1.6 million to a team of University of Cincinnati (UC) researchers to study the unusual lung disease, pulmonary alveolar microlithiasis (PAM). The study’s principal investigator is Francis X. McCormack, MD, Director of the Division of Pulmonary, Critical Care and Sleep Medicine
Read more →
- Posted in
- News

- 19 OCT 15
UC Medical Center One of Most Connected Hospitals
Read more →
- Posted in
- News
- 20 AUG 15
First FDA-Approved Treatment for LAM Spearheaded by UC Research
The Food and Drug Administration (FDA) recently approved the drug sirolimus for the treatment of lymphangioleiomyomatosis (LAM), a rare lung disorder primarily affecting women. The Multicenter International Lymphangioleiomyomatosis Efficacy and Safety of Sirolimus (MILES) trial, spearheaded by investigators at the University of Cincinnati Medical Center Division of Pulmonary, Critical Care & Sleep Medicine and Cincinnati
Read more →
- Posted in
- News
- 13 AUG 15
C-STARS Simulation Center Helps U.S. Air Force Medical Personnel Train
The University of Cincinnati Medical Center houses one of only three Centers for the Sustainment of Trauma and Readiness Skills (C-STARS) selected by the U.S. Air Force and is the only such center to focus on air evacuation of critically injured patients. Since its inception in 2002, the C-STARS program has trained personnel to be
Read more →
- Posted in
- News

Home

Translational Pulmonary Science Center Uses Basic Science to Advance Diagnosis and Treatment of Rare Lung Diseases in Real Time

Diffuse Cystic Lung Diseases: Definitive Diagnosis is Essential for Targeted Treatments

Groundbreaking Research into Rare Lung Disease Pulmonary Alveolar Microlithiasis

UC Medical Center One of Most Connected Hospitals

First FDA-Approved Treatment for LAM Spearheaded by UC Research

C-STARS Simulation Center Helps U.S. Air Force Medical Personnel Train

University of Cincinnati Medical Center

Newest Articles